CompletedNot Applicable

Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure

United States1,136 participantsStarted 2025-04-04

Plain-language summary

This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Health (NYULH), and will now test and implement this alert across three other health systems.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with an encounter visit at participating cardiology practice during the study period * Patient with EF of less than or equal to 40% on most recent echocardiogram at the time of visit * Patient ages 18-90 Exclusion Criteria: * Pregnancy * Ventricular assist device * Hospice * Cardiac amyloid * Medication-specific exclusion for MRA: most recent systolic blood pressure less than 105 mm Hg, most recent potassium \< 5.1, any potassium \> 5.5, most recent glomerular filtration rate \< 30 (using MDRD equation), or a documented MRA allergy.

What they're measuring

Number of Patients with a Prescription for Mineralocorticoid Antagonists (MRA)

Timeframe: Up to Day 30

Trial details

NCT IDNCT06457152

SponsorNYU Langone Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-04

View on ClinicalTrials.gov More Heart Failure trials